(QLC) US Quality Large Cap - Overview
Etf: Large-Cap, US, Quality, Value, Momentum
Dividends
| Dividend Yield | 1.03% |
| Yield on Cost 5y | 1.89% |
| Yield CAGR 5y | 11.16% |
| Payout Consistency | 94.8% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 13.8% |
| Relative Tail Risk | 3.81% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.93 |
| Alpha | 7.11 |
| Character TTM | |
|---|---|
| Beta | 0.950 |
| Beta Downside | 0.956 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.49% |
| CAGR/Max DD | 1.29 |
Description: QLC US Quality Large Cap December 27, 2025
The FlexShares US Quality Large-Cap Index Fund (BATS:QLC) tracks an index that emphasizes U.S. large-cap stocks with higher exposure to quality, value, and momentum factors than the broader large-cap universe. In normal conditions the fund invests at least 80% of its net assets (excluding securities-lending collateral) in the constituent securities of that index.
Key metrics as of the latest filing: an expense ratio of 0.15%, assets under management around $1.2 billion, and a top-10 holding concentration of roughly 30%, led by firms such as Apple, Microsoft, and Johnson & Johnson. The fund’s factor tilt tends to favor sectors with strong cash-flow generation-particularly technology, health care, and consumer staples-while underweighting cyclical industries that are more sensitive to interest-rate fluctuations. Recent macro-economic drivers, including a resilient U.S. GDP growth rate (~2.5% annualized) and a flattening yield curve, have supported the performance of high-quality large caps.
If you want a deeper, data-driven look at how QLC’s factor exposures compare to peers, ValueRay offers a free analytics dashboard that can help you quantify the trade-off between quality tilt and sector risk.
What is the price of QLC shares?
Over the past week, the price has changed by +0.91%, over one month by +0.40%, over three months by +5.83% and over the past year by +21.70%.
Is QLC a buy, sell or hold?
What are the forecasts/targets for the QLC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 100.7 | 21.2% |
QLC Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 764.8m USD (764.8m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 764.8m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 764.8m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.41% (E(764.8m)/V(764.8m) * Re(9.41%) + (debt-free company))
Discount Rate = 9.41% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)